What is the recommended imaging protocol for parathyroid disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Parathyroid Imaging Protocol

For initial imaging of primary hyperparathyroidism, order either ultrasound of the parathyroid glands OR sestamibi dual-phase scan with SPECT/CT—these are equivalent first-line options, though using both together maximizes localization accuracy. 1

Clinical Context Before Imaging

  • Imaging has no role in diagnosing hyperparathyroidism—the diagnosis is purely biochemical (elevated or inappropriately normal PTH with elevated serum calcium). 2
  • Only order imaging after biochemical confirmation for preoperative localization purposes. 2, 3

Primary Hyperparathyroidism (PHPT) - Initial Imaging

First-Line Options (Choose One or Both)

Ultrasound Parathyroid:

  • Sensitivity of 57-90% depending on operator experience and presence of thyroid disease. 4, 5
  • Excellent for typical juxtathyroid adenomas but poor for ectopic glands (only 7% sensitivity for ectopic locations). 1, 3
  • Provides simultaneous thyroid evaluation. 1, 3
  • No radiation exposure—particularly valuable in pediatric patients. 1

Sestamibi Dual-Phase Scan with SPECT/CT:

  • Sensitivity ranges 67-86% with SPECT/CT, significantly better than planar imaging alone (70%). 1, 3
  • SPECT/CT improves localization from 42% (planar) to 67% (SPECT) to 86% (SPECT/CT). 1
  • Superior to planar techniques for multigland disease detection. 1

Combined Approach (Recommended for Optimal Results):

  • When both ultrasound and sestamibi SPECT/CT are concordant, sensitivity reaches 78-89%. 4, 5, 3
  • Concordant imaging allows confident minimally invasive parathyroidectomy. 1

Alternative First-Line Options

CT Neck with and without IV contrast or sestamibi scan with I-123 or pertechnetate thyroid scan are also considered usually appropriate initial imaging. 1

Factors That Decrease Imaging Sensitivity

  • Multigland disease (sensitivity drops to 24-66%). 1
  • Concomitant nodular thyroid disease. 1, 5
  • Small adenomas (<500mg). 1, 3
  • Mild hypercalcemia. 1, 3

Recurrent or Persistent PHPT After Surgery

Use the same imaging options as initial PHPT, but consider more aggressive multimodal approach:

  • Ultrasound, CT neck with contrast, sestamibi with SPECT/CT, or dual-tracer techniques are all usually appropriate. 1
  • These modalities should be used complementarily to maximize confidence via concordant results. 1
  • Consider selective venous sampling if noninvasive imaging is nonlocalizing, equivocal, or discordant. 1

Secondary and Tertiary Hyperparathyroidism

Initial imaging options:

  • Ultrasound parathyroid, CT neck with contrast, sestamibi dual-phase scan, or sestamibi with SPECT/CT are usually appropriate. 1
  • Goal is to identify all eutopic and ectopic/supernumerary glands since these are typically multigland diseases. 1
  • Sestamibi sensitivity is lower in this population (29-59% per lesion for ectopic glands). 1
  • Ultrasound sensitivity for ectopic glands is particularly poor (7-32%). 1

Controversial options:

  • Sestamibi with I-123 or pertechnetate thyroid scans have insufficient evidence in secondary/tertiary hyperparathyroidism—the ACR panel did not reach consensus on these. 1

Pediatric Considerations

  • Sestamibi is useful only in older children with single adenomas in sporadic PHPT. 1
  • Sestamibi adds minimal information beyond ultrasound in neonates or familial PHPT. 1
  • Prioritize ultrasound to minimize radiation exposure. 1

Common Pitfalls to Avoid

  • Never use imaging to diagnose hyperparathyroidism—only for localization after biochemical confirmation. 2, 3
  • Do not rely on planar sestamibi alone—always add SPECT or SPECT/CT for improved sensitivity (86% vs 70%). 1, 3
  • Do not use only one imaging modality for ectopic glands—ultrasound misses 93% of ectopic locations. 1, 3
  • Expect lower sensitivity with multigland disease, thyroid nodules, or small adenomas—consider complementary imaging upfront in these scenarios. 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Confirmation of Primary Hyperparathyroidism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Preoperative Imaging for Parathyroid Gland Localization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.